Generate Biomedicines, Inc. (GENB)

Generate Biomedicines Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024
Period Ending	Apr 28, 2026	Dec 31, 2025	Dec 31, 2024
Debt / Equity Ratio	0.28	0.28	0.17
Debt / EBITDA Ratio	-0.31	-0.31	-0.42
Debt / FCF Ratio	-0.34	-0.34	-0.63
Net Debt / Equity Ratio	0.25	0.25	0.73
Net Debt / EBITDA Ratio	0.69	0.69	1.74
Net Debt / FCF Ratio	0.75	0.75	2.61
Asset Turnover	0.08	0.08	0.04
Quick Ratio	2.69	2.69	4.55
Current Ratio	2.85	2.85	4.70
Return on Equity (ROE)	-82.06%	-82.06%	-51.13%
Return on Assets (ROA)	-55.37%	-55.37%	-37.96%
Return on Invested Capital (ROIC)	-293.84%	-293.84%	-202.39%
Return on Capital Employed (ROCE)	-69.18%	-69.18%	-45.63%
Buyback Yield / Dilution	-	-2.77%	-
Total Shareholder Return	-	-2.77%	-

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q